AngioDynamics (NASDAQ:ANGO – Free Report) had its price target cut by HC Wainwright from $20.00 to $18.00 in a research note released on Monday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock. HC Wainwright also issued estimates for AngioDynamics’ Q3 2024 earnings at ($0.12) EPS, Q4 2024 earnings at […]